AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Faruqi & Faruqi Investigates Semler Scientific Securities Lawsuit
ByAinvest
Sunday, Sep 7, 2025 9:23 am ET1min read
Faruqi & Faruqi LLP is investigating potential claims against Semler Scientific, a biotech company, for alleged securities fraud. Investors who purchased or acquired Semler Scientific securities between March 10, 2021, and April 15, 2025, may be eligible to seek lead plaintiff status in a federal securities class action. The deadline to do so is October 28, 2025. Those interested can contact Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) or click the link provided for additional information.
Investors in Semler Scientific Inc. (NASDAQ: SMLR) may have a legal recourse against the biotech company following recent revelations. Faruqi & Faruqi LLP, a leading securities fraud law firm, is investigating potential claims against Semler Scientific for alleged securities fraud. The firm is encouraging investors who purchased or acquired Semler Scientific securities between March 10, 2021, and April 15, 2025, to seek lead plaintiff status in a federal securities class action.The deadline to do so is October 28, 2025. Those interested can contact Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) or click the link provided for additional information.
Semler Scientific faced scrutiny when it disclosed in February 2025 that there was a risk of a civil False Claims Act lawsuit by the U.S. Department of Justice (DOJ) regarding its QuantaFlo device. The company's stock price fell by 9.4% on this news. Later, on April 15, 2025, Semler Scientific announced a settlement agreement with the DOJ for $29.75 million, which further impacted the stock price [1].
The class action lawsuit alleges that Semler Scientific made materially false and misleading statements during the Class Period, failing to disclose a material investigation by the DOJ into violations of the False Claims Act. This led to investors suffering damages when the true details entered the market [2][3].
Investors are urged to act promptly to protect their rights. Faruqi & Faruqi LLP has a proven track record in representing investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide.
References:
[1] https://www.morningstar.com/news/business-wire/20250903792103/glancy-prongay-murray-llp-a-leading-securities-fraud-law-firm-encourages-semler-scientific-inc-smlr-investors-to-inquire-about-securities-fraud-class-action
[2] https://www.morningstar.com/news/globe-newswire/9521771/smlr-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-semler-scientific-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit
[3] https://www.morningstar.com/news/globe-newswire/9524494/rosen-the-first-filing-firm-encourages-semler-scientific-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-commenced-by-the-firm-smlr
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet